chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Lack Of Apeptite; Hot Flash; Severe Diarrhea; Fever; Chill; Extreme Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8732) via an unspecified route of administration in the left arm on 30Mar2021 at 17:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 31Mar2021 at 16:30 the patient experienced lack of appetite, hot flash, severe diarrhea, fever, chill and had extreme exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event lack of appetite, hot flash, severe diarrhea, fever, chill and extreme exhaustion were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Peripheral swelling
Clinical narrative: swelling in right hand.; headache; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7533) via an unspecified route of administration in the arm left on 31Mar2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history reported as cancer survivor. The patient's allergies to medications, food, or other products were reported as nine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 09:00 the patient experienced swelling in right hand and had headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. The clinical outcome of events swelling in right hand and headache were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Pain, Pyrexia
Clinical narrative: Body aches; Diarrhea; Fever 102; Chills; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205), via an unspecified route of administration in the arm left on 15Mar2021 at 13:45 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, COVID-19 and penicillin allergy. The patient received other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6200), via an unspecified route of administration in the left arm on 22Feb2021 at 13:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 at 02:00 the patient experienced Body aches. The patient did not receive any treatment for the event. On 16Mar2021 at 02:00, the patient experienced fever 102, chills, body aches and diarrhea for 24 hours. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 16Mar2021, the patient underwent lab test which included body temperature and the result was 102 (units unspecified). The clinical outcome of the events fever 102, chills, body aches and diarrhea were resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Very strong unbearable pain on the left lower back side; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 5W0150) via an unspecified route of administration in the left arm on 31Mar2021 at 11:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient was in good shape and workout daily. Concomitant medications included levothyroxine 137 mcg (MANUFACTURER UNKNOWN) and atorvastatin 40 mg (MANUFACTURER UNKNOWN); both were taken for unspecified indication since unspecified dates. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 11:30, exactly 24 hours after the vaccination, the patient experienced very strong unbearable pain on the left lower back side. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of unbearable pain on the left lower back side and included treating with 02 doses of Advil in 04 hr intervals, three times in a day. On 02Apr2021, next morning the patient felt better but during the day still had pain in the same area but able to tolerate with no medicine. The clinical outcome of the event very strong unbearable pain on the left lower back side was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Feeling of body temperature change, Headache
Clinical narrative: Slight dizziness; Fatigue; nausea; Body ache; Sore shoulder; Stiff shoulder; getting hot then cold with no fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 01Apr2021 at 14:15(at the age of 24-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included Advil, Amphet/Dextr, Buspirone, Vitamin D3 (MANUFACTURER UNKNOWN FOR ALL) from unknown date for unknown indication. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 07:45 the patient experienced Slight dizziness. On 02Apr2021 at 07:45 the patient experienced Fatigue. On 02Apr2021 at 07:45 the patient experienced nausea. On 02Apr2021 at 07:45 the patient experienced Body ache. On 02Apr2021 at 07:45 the patient experienced Stiff shoulder. On 02Apr2021 at 07:45 the patient experienced Sore shoulder. On 02Apr2021 at 07:45 the patient experienced getting hot then cold with no fever. On 02Apr2021 at 07:45 the patient experienced Headache. The clinical outcome of the event slight dizziness, fatigue, nausea, body ache, stiff shoulder, sore shoulder, getting hot then cold with no and headache was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Nausea, Pain
Clinical narrative: Slight dizziness; Fatigue; nausea; Body ache; Sore shoulder; Stiff shoulder; getting hot then cold with no fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 01Apr2021 at 14:15(at the age of 24-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included Advil, Amphet/Dextr, Buspirone, Vitamin D3 (MANUFACTURER UNKNOWN FOR ALL) from unknown date for unknown indication. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 07:45 the patient experienced Slight dizziness. On 02Apr2021 at 07:45 the patient experienced Fatigue. On 02Apr2021 at 07:45 the patient experienced nausea. On 02Apr2021 at 07:45 the patient experienced Body ache. On 02Apr2021 at 07:45 the patient experienced Stiff shoulder. On 02Apr2021 at 07:45 the patient experienced Sore shoulder. On 02Apr2021 at 07:45 the patient experienced getting hot then cold with no fever. On 02Apr2021 at 07:45 the patient experienced Headache. The clinical outcome of the event slight dizziness, fatigue, nausea, body ache, stiff shoulder, sore shoulder, getting hot then cold with no and headache was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Eye pruritus, Fatigue, Paraesthesia
Clinical narrative: Extreme fatigue; Itchy eyes; Tingling in face; Tingly turned into burning; Face is red and itching and swollen.; Face is red and itching and swollen.; Face is red and itching and swollen.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the left arm on 01Apr2021 08:15 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history included lupus, rheumatoid arthritis, obesity and cold urticaria. The patient was allergic to tramadol and imuran. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN) 2.5 mg x 6, one weekly, folic acid (MANUFACTURER UNKNOWN) and multi (MANUFACTURER UNKNOWN), all taken for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:25, 10 minutes after injection, the patient experienced itchy eyes and tingling in face. Thought nothing of it since she could not see a rash. The patient experienced extreme fatigue 3 hours later and slept on and off. Tingly turned into burning and overnight face was red, itching and swollen. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measure taken as a result of the events included antihistamines (MANUFACTURER UNKNOWN). The clinical outcome of the events itchy eyes and tingling in face, extreme fatigue, tingling turned into burning and overnight face was red, itching and swollen were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling face
Clinical narrative: Extreme fatigue; Itchy eyes; Tingling in face; Tingly turned into burning; Face is red and itching and swollen.; Face is red and itching and swollen.; Face is red and itching and swollen.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the left arm on 01Apr2021 08:15 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history included lupus, rheumatoid arthritis, obesity and cold urticaria. The patient was allergic to tramadol and imuran. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN) 2.5 mg x 6, one weekly, folic acid (MANUFACTURER UNKNOWN) and multi (MANUFACTURER UNKNOWN), all taken for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:25, 10 minutes after injection, the patient experienced itchy eyes and tingling in face. Thought nothing of it since she could not see a rash. The patient experienced extreme fatigue 3 hours later and slept on and off. Tingly turned into burning and overnight face was red, itching and swollen. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measure taken as a result of the events included antihistamines (MANUFACTURER UNKNOWN). The clinical outcome of the events itchy eyes and tingling in face, extreme fatigue, tingling turned into burning and overnight face was red, itching and swollen were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Lethargy, Pyrexia, Rash erythematous
Clinical narrative: Extremely lethargic; 102 fever for 24 hours; After fever broke red rash formed on both sides of neck and went from chin, down the neck to the bottom of chest, rash last 2 days; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Er8733) via an unspecified route of administration in the left arm on 29Mar2021 at 14:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfonamide. Concomitant medications and past drug were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: En6206) via an unspecified route of administration in the left arm on 08Mar2021 at 14:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 23Mar2021 at 06:00, the patient experienced 102 (unit unspecified) fever for 24 hours, the patient was extremely lethargic and after fever broke red rash formed on both sides of her neck and went from her chin, down on to her neck to the bottom of her chest. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and  emergency room or department or urgent care. The patient did not receive any treatment for the reported adverse events. The clinical outcome of the events fever was recovered on 24Mar2021, after the duration of 24 hours, while that of red rash recovered on 25Mar2021, after the duration of 2 days and lethargic recovered on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash pruritic
Clinical narrative: Tiny blisters; Itchy rash; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the arm left on 25Mar2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. The patient had allergic reactions to pneumonia vaccine and rheumatoid arthritis medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included upadacitinib (RINVOQ), hydroxychloroquine (MANUFACTURER UNKNOWN), pilocarpine (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN). The patient did receive other unspecified vaccine within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: P6955) via an unspecified route of administration in the arm left on 04Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 29Mar2021 at 16:00 (Monday afternoon) the patient started developing an itchy rash with some tiny blisters. On 01Apr2021 (Thursday), it covered almost completely on the patient's back, arms, and legs, and to a lesser extent my chest, neck, and face. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of events which included treatment with Zyrtec twice a day since 30Mar2021 (Tuesday) and did put triamcinolone acetone on it on 01Apr2021 (Thursday) night. The clinical outcome of events tiny blisters and itchy rash were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Nausea, Pain
Clinical narrative: Headache; Body Aches; Chills; Diarrhea; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the left arm on 25Mar2021 at 10:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6204) via an unspecified route of administration in the left arm on 04Mar2021 at 10:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Mar2021 at 21:30, the patient experienced headache, body aches, chills, diarrhoea and nausea. Therapeutic measures were taken for the reported event and included treatment with pain pills. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, body aches, chills, diarrhoea and nausea were recovered on unknown date.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 31Mar2021 at 13:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Patient did not have any medical history. The patient did not receive any medication within two weeks of vaccination. Patient did not report any allergy to food, medication and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 19:00, the patient experienced injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event injection site pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Malaise, Pain in extremity, Pyrexia
Clinical narrative: Sore Left arm; significant fatigue; general malaise; temperature of 100.6; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 30Mar2021 at 09:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included traumatic brain injury and major depression. The patient had drug allergy to Lexapro. Concomitant medications included fluticasone propionate (FLONASE), guaifenesin (MUCINEX), loratadine (CLARITIN) and vitamin d nos (VITAMIN D), all for unknown indications from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 13:30, the patient experienced sore left arm, significant fatigue, general malaise and temperature of 100.6. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of pain in left arm, fatigue, general  malaise and low grade fever  was recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort
Clinical narrative: head pressure similar to sinus pressure every time I cough or laugh hard since 2nd dose. No sinus pain and head pressure located above left eye; This is a spontaneous report from a contactable nurse, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 16Mar2021 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included factor IV leiden and COVID-19. The patient had a history of allergy to pineapple. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 23Feb2021 at 16:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021 at 17:00, the patient experienced head pressure similar to sinus pressure every time she coughed or laughed hard since second dose. No sinus pain and head pressure located above left eye. The patient did not receive any treatment for the reported event. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event head pressure similar to sinus pressure every time when the patient coughed or laughed hard was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Glossodynia, SARS-CoV-2 test, Skin exfoliation, Tongue erythema
Clinical narrative: Skin sloughed off on entire surface inside of mouth and lips.; Tongue red; Tongue painful; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8732) via an unspecified route of administration in the left arm on 22Mar2021 at 14:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune disease with hashimoto's. The patient was not allergic to medications, food, or other products. Concomitant medications included levothyroxine sodium (SYNTHROID) and thyroid (ARMOUR THYROID). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 31Mar2021, the patient's skin sloughed off on entire surface inside of mouth and lips, also tongue was painful and red. On the same day, post vaccination, the patient underwent Helix (SARS-CoV-2) test and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse events. The clinical outcome of the events skin sloughed off on entire surface inside of mouth and lips, tongue was painful and red was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Ear discomfort, Lymphadenopathy, Seasonal allergy, Tonsillar hypertrophy
Clinical narrative: Having seasonal allergies and it made them exponentially worse; Having seasonal allergies and it made them exponentially worse; Swollen tonsils; Pin inside ears; Swollen lymph nodes in my neck; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 31Mar2021 at 12:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies which was ongoing. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 19:00, after vaccination the patient's seasonal allergies became exponentially worse. The patient also experienced swollen lymph nodes in neck, swollen tonsils and pin inside ears. The events resulted in doctor/other healthcare professional office/clinic visit. The patient's doctor believed that the events were related to vaccine administration. The patient received treatment with steroid and other unspecified pain relief pills. The clinical outcome of the events vaccine made seasonal allergies exponentially worse, swollen lymph nodes in neck, swollen tonsils in neck and pin inside ears was not resolved at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Feel light headed all the time.; This is a spontaneous report from a contactable consumer, the patient. A 74-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the arm left on 04Feb2021 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247 in left arm on 14Jan2021 at 17:30 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Patient received other medications in two weeks which included clonazepam (KLONOPIN), vitamin D (MANAFACTURER UNKNOWN), revuvastatin (MANAFACTURER UNKNOWN), ca (MANAFACTURER UNKNOWN), vitamin (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. On 06Feb2021, the patient noticed that in the month and a half since last vaccine, she felt light headed all the time. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of dizziness was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER87337) via an unspecified route of administration in the right arm on 01Apr2021 at 13:30 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported.  Concomitant medications included vitamin C (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN), all taken from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 11Mar2021 at 13:30 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. On 02Apr2021 at 14:00, after the second dose, second day following vaccination, the patient experienced fever and chills. Therapeutic measure taken as a result of the events experienced included aspirin (MANUFACTURER UNKNOWN). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever and chills was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness
Clinical narrative: Dizziness; Joint aches; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the left arm on 01Apr2021 at 09:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient had a history of allergy to penicillin. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via an unspecified route of administration in the left arm on 11Mar2021 at 08:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 21:00, 12 hours after second dose, the patient experienced joint aches and dizziness and still continued for 17 hours at the time of this report. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events joint aches and dizziness was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives all over body; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP69SS) via an unspecified route of administration in the left arm on 27Mar2021 at 11:15 as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, the patient experienced hives all over body. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event hives was not resolved.   No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: a week after the second shot I developed Shingles.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ENG6201) via an unspecified route of administration in the a right arm on 03Mar2021 at 15:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot Number: ER6206) via an unspecified route of administration in the right arm on 23Feb2021 at 15:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 24Mar2021, a week after the second shot the patient experienced shingles. The patient also reported that his father in law had the same thing happened to him after the first Pfizer shot. The adverse event resulted in a visit to the doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken and included treatment with valacyclovir. The clinical outcome of the event shingles was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021374076 same reporter/drug/event, different patient
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: swollen lymph node in left shoulder; swollen lymph node in left shoulder that moves and was painful first couple days; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 26Mar2021 at 14:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. The patient medical history included GERD, blood pressure high, clot blood and the patient was allergic to albuterol. Concomitant medications included xerolto (MANUFACTURER UNKNOWN), bystolic (MANUFACTURER UNKNOWN) and pantoprazole (MANUFACTURER UNKNOWN) taken with in two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 05Mar2021 at 14:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021, the patient experienced lymphadenopathy and lymph node pain. The patient reported that she had swollen lymph node in left shoulder that move and was painful first couple days but subsided, still swollen but less so one week later. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lymphadenopathy and lymph node pain were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Confusional state, Dizziness, Fatigue
Clinical narrative: Low grade fever (99.2); Fatigue; Joint pain; Hot flash; Dizzy; Blurred vision; Heart palpitations; Mild confusion; Forgetfulness; Injection site pain; Intermittent burning and stinging of skin in various locations; Intermittent burning and stinging of skin in various locations; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 19Mar2021 at 10:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, right bundle branch block, premature ventricular contractions, gout, osteoarthritis, fibromyalgia, depression and anxiety. The patient was allergic to ultram, tramadol, pseudoephedrine, sensitive to NSAIDs and sensitive to morphine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 19Mar2021 at 10:05, first 5 min, the patient experienced with hot flash, dizzy, blurred vision and heart palpitations. The patient felt fine. On an unknown date in Mar2021, the patient had two days of mild confusion, forgetfulness, injection site pain (for 10 days limited ROM), intermittent burning and stinging of skin in various locations. On 23Mar2021, on day 4, the patient experienced fatigue and joint pain. On 29Mar2021, day 10, the patient had low grade fever (99.2). The events did worsen each day peaking day 12 on 31Mar2021 and mild improvement on day 13 on 01Apr2021 and on day 14 on 02Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 29Mar2021, the patient underwent lab test which included body temperature test which measured low grade fever (99.2). Therapeutic measures were not taken as a result of events. The clinical outcome of events hot flash, dizzy, blurred vision, heart palpitations, mild confusion, forgetfulness, injection site pain, intermittent burning, stinging of skin, fatigue, joint pain and low-grade fever (99.2) were resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Memory impairment, Pain of skin, Palpitations, Pyrexia
Clinical narrative: Low grade fever (99.2); Fatigue; Joint pain; Hot flash; Dizzy; Blurred vision; Heart palpitations; Mild confusion; Forgetfulness; Injection site pain; Intermittent burning and stinging of skin in various locations; Intermittent burning and stinging of skin in various locations; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 19Mar2021 at 10:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, right bundle branch block, premature ventricular contractions, gout, osteoarthritis, fibromyalgia, depression and anxiety. The patient was allergic to ultram, tramadol, pseudoephedrine, sensitive to NSAIDs and sensitive to morphine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 19Mar2021 at 10:05, first 5 min, the patient experienced with hot flash, dizzy, blurred vision and heart palpitations. The patient felt fine. On an unknown date in Mar2021, the patient had two days of mild confusion, forgetfulness, injection site pain (for 10 days limited ROM), intermittent burning and stinging of skin in various locations. On 23Mar2021, on day 4, the patient experienced fatigue and joint pain. On 29Mar2021, day 10, the patient had low grade fever (99.2). The events did worsen each day peaking day 12 on 31Mar2021 and mild improvement on day 13 on 01Apr2021 and on day 14 on 02Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 29Mar2021, the patient underwent lab test which included body temperature test which measured low grade fever (99.2). Therapeutic measures were not taken as a result of events. The clinical outcome of events hot flash, dizzy, blurred vision, heart palpitations, mild confusion, forgetfulness, injection site pain, intermittent burning, stinging of skin, fatigue, joint pain and low-grade fever (99.2) were resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Skin burning sensation, Vaccination site pain, Vision blurred
Clinical narrative: Low grade fever (99.2); Fatigue; Joint pain; Hot flash; Dizzy; Blurred vision; Heart palpitations; Mild confusion; Forgetfulness; Injection site pain; Intermittent burning and stinging of skin in various locations; Intermittent burning and stinging of skin in various locations; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 19Mar2021 at 10:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, right bundle branch block, premature ventricular contractions, gout, osteoarthritis, fibromyalgia, depression and anxiety. The patient was allergic to ultram, tramadol, pseudoephedrine, sensitive to NSAIDs and sensitive to morphine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 19Mar2021 at 10:05, first 5 min, the patient experienced with hot flash, dizzy, blurred vision and heart palpitations. The patient felt fine. On an unknown date in Mar2021, the patient had two days of mild confusion, forgetfulness, injection site pain (for 10 days limited ROM), intermittent burning and stinging of skin in various locations. On 23Mar2021, on day 4, the patient experienced fatigue and joint pain. On 29Mar2021, day 10, the patient had low grade fever (99.2). The events did worsen each day peaking day 12 on 31Mar2021 and mild improvement on day 13 on 01Apr2021 and on day 14 on 02Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 29Mar2021, the patient underwent lab test which included body temperature test which measured low grade fever (99.2). Therapeutic measures were not taken as a result of events. The clinical outcome of events hot flash, dizzy, blurred vision, heart palpitations, mild confusion, forgetfulness, injection site pain, intermittent burning, stinging of skin, fatigue, joint pain and low-grade fever (99.2) were resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Received the shot 4 days ago immediately 40 mins later my face started tingly and it is day 4 now and its tingly on left side and numb like pins and needles; Received the shot 4 days ago immediately 40 mins later my face started tingly and it is day 4 now and it's tingly on left side and numb like pins and needles; numb like pins and needles; This is a spontaneous report from a contactable healthcare professional, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PFIZERER0733) via an unspecified route of administration in the right arm on 29Mar2021 at 17:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medication within two weeks of vaccination. The patient did not report any known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 29Mar2021 at 18:15 immediately 40 minutes after the vaccination, the patient face started tingly and it was day 4 and it was tingly on left side and numb like pins and needles. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Treatment was not received for the reported events. The clinical outcome of the events tingly, numb, like pins and needles were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.